References
1. Chow WH, Devesa SS, Warren JL, et al. Rising incidence of renal cell cancer in the United States. J Am Med Assoc 1999; 281:17-1628.
2. Ferlay J, Foucher ES, Tieulent JL, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur. J. Cancer 2013; 49:6-1374.
3. Haferkamp A, Bastian PJ, Jakobi H, et al. Renal cell carcinoma with tumor thrombus extension ınto the vena cava: Prospective long-term . J Urol 2007; 177:5-1703.
4. Berg AA. Malignant hypernephroma of the kidney, its clinical course, and diagnosis, with a description of the author’s method of radical operative cure. Surg Gynecol Obs 1913; 17:446-71.
5. Rigaud J, Hetet JF, Braud G, et al. Surgical care, morbidity, mortality and after nephrectomy for renal cancer with extension of tumor thrombus into the ınferior vena cava: Retrospective study since 1990s. Eur Urol 2006; 50:2-302.
6. Zisman A, Wieder JA, Pantuck AJ, et al. Renal cell carcinoma with tumor thrombus extension: Biology, role of nephrectomy and response to immunotherapy. J Urol 2003; 169:3-909.
7. Cao C, Bi X, Liang J, et al. Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus. BMC Cancer 2019; 19:1-144.
8. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47:11-1245.
9. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J of Clin Oncol 1982; 5:6-649.
10. Blute ML, Leibovich BC, Lohse CM, et al. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumor thrombus. BJU Int 2004; 94:1-33.
11. Wolters U, Wolf T, Stützer H, et al. ASA classification and perioperative variables as predictors of postoperative outcome. Br J Anaesth 1996; 77:2-217.
12. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery 2004; 240:2-205.
13. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Ann of Surg Oncol 2010;17-1471.
14. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. The Am J of Surg Oncol 1982; 6:7-655.
15. Beisland C, Guðbrandsdottir G, Reisæter LAR. A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: Evaluation after eight years of clinical use. World J Urol 2016; 34:8-1087.
16. Mager R, Daneshmand S, Evans CP, et al. Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival. J Surg Oncol 2016; 114:6-764.
17. Skinner DG, Pritchett TR, Lieskovsky G, et al. Vena caval involvement by renal cell carcinoma: Surgical resection provides meaningful long-term survival. Ann Surg 1989; 210:3-387.
18. Zhu H, Wang Q, Wang M. Surgical management of renal cell carcinoma extending into venous system: A 20-year experience. Scand J Surg 2018; 107:2-158.
19. Ciancio M, Manoharan M, Katkoori D, et al. Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: Single-center experience. Eur Urol 2010; 57:4-667.
20. Méjean A, Ravaud A, Thezenas S, et al. Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma. N Engl J Med 2018; 379:5-417.
21. Bex A, Mulders P, Jewett M, et al. Comparison of ımmediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: The SURTIME randomized clinical trial. JAMA Oncology 2019; 5:2-164.
22. Rabbani F, Hakimian P, Reuter VE, et al. Renal vein or inferior vena caval extension in patients with renal cortical tumors: Impact of tumor histology. J Urol 2004; 171:3-1057.
23. Agochukwu N, Shuch B. Clinical management of renal cell carcinoma with venous tumor thrombus. World J Urol 2014; 32:3-581.
24. Wagner B, Patard JJ, Mejean A, et al. Prognostic value of renal vein and ınferior vena cava involvement in renal cell carcinoma. Eur Urol 2009; 55:2-452.
25. Choi DK, Jeon HG, Jeong CW, et al. Surgical treatment of renal cell carcinoma: Can morphological features of inferior vena cava tumor thrombus on computed tomography or magnetic resonance imaging be a prognostic factor? Int J Urol; 24:2-102.
26. Al Otaibi M, Youssif TA, Alkhaldi A, et al. Renal cell carcinoma with inferior vena caval extension: Impact of tumor extent on surgical outcome. BJU Int 2009;104:10-1467.
27. Berczi A, Flasko T, Szerafin T, et al. Surgical management and outcome of renal cell carcinoma with ınferior vena cava tumor thrombus. Urol Int 2017; 99:3-267.
28. Glazer AA, Novick AC. Long-term follow-up after surgical treatment for renal cell carcinoma extending into the right atrium. J Urol 1996; 155:2-448.
29. Frank I, Blute ML, Cheville JC, et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score. J Urol 2002; 168:6-2395.